BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 12588649)

  • 61. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
    J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries.
    Burns WR; Wang Y; Tang PC; Ranjbaran H; Iakimov A; Kim J; Cuffy M; Bai Y; Pober JS; Tellides G
    Am J Transplant; 2005 Jun; 5(6):1226-36. PubMed ID: 15888026
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chemokine receptor 5 and its ligands in the immune response to murine tuberculosis.
    Badewa AP; Quinton LJ; Shellito JE; Mason CM
    Tuberculosis (Edinb); 2005 May; 85(3):185-95. PubMed ID: 15850756
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
    Taylor PC; Peters AM; Paleolog E; Chapman PT; Elliott MJ; McCloskey R; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Jan; 43(1):38-47. PubMed ID: 10643698
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cultured rat microglia express functional beta-chemokine receptors.
    Boddeke EW; Meigel I; Frentzel S; Gourmala NG; Harrison JK; Buttini M; Spleiss O; Gebicke-Härter P
    J Neuroimmunol; 1999 Aug; 98(2):176-84. PubMed ID: 10430051
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
    Matejuk A; Adlard K; Zamora A; Silverman M; Vandenbark AA; Offner H
    J Neurosci Res; 2001 Sep; 65(6):529-42. PubMed ID: 11550221
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier.
    McMahon EJ; Cook DN; Suzuki K; Matsushima GK
    J Immunol; 2001 Sep; 167(5):2964-71. PubMed ID: 11509646
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease.
    Garlet GP; Martins W; Ferreira BR; Milanezi CM; Silva JS
    J Periodontal Res; 2003 Apr; 38(2):210-7. PubMed ID: 12608917
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Beta-chemokine function in experimental lung ischemia-reperfusion injury.
    Krishnadasan B; Farivar AS; Naidu BV; Woolley SM; Byrne K; Fraga CH; Mulligan MS
    Ann Thorac Surg; 2004 Mar; 77(3):1056-62. PubMed ID: 14992926
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytes.
    Møller AS; Øvstebø R; Westvik AB; Joø GB; Haug KB; Kierulf P
    J Endotoxin Res; 2003; 9(6):349-60. PubMed ID: 14733721
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver.
    Hokeness KL; Kuziel WA; Biron CA; Salazar-Mather TP
    J Immunol; 2005 Feb; 174(3):1549-56. PubMed ID: 15661915
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chemokine regulation of macrophage recruitment into the olfactory epithelium following target ablation: involvement of macrophage inflammatory protein-1alpha and monocyte chemoattractant protein-1.
    Getchell TV; Subhedar NK; Shah DS; Hackley G; Partin JV; Sen G; Getchell ML
    J Neurosci Res; 2002 Dec; 70(6):784-93. PubMed ID: 12444600
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The second extracellular loop of CCR5 is the major determinant of ligand specificity.
    Samson M; LaRosa G; Libert F; Paindavoine P; Detheux M; Vassart G; Parmentier M
    J Biol Chem; 1997 Oct; 272(40):24934-41. PubMed ID: 9312096
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions.
    Kirkaldy AA; Musonda AC; Khanolkhar-Young S; Suneetha S; Lockwood DN
    Clin Exp Immunol; 2003 Dec; 134(3):447-53. PubMed ID: 14632750
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of vitamin D3 on chemokine expression in pulmonary tuberculosis.
    Selvaraj P; Harishankar M; Singh B; Banurekha VV; Jawahar MS
    Cytokine; 2012 Oct; 60(1):212-9. PubMed ID: 22800603
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Crucial role of CCL3/MIP-1alpha in the recurrence of autoimmune anterior uveitis induced with myelin basic protein in Lewis rats.
    Manczak M; Jiang S; Orzechowska B; Adamus G
    J Autoimmun; 2002 Jun; 18(4):259-70. PubMed ID: 12144807
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment.
    Tillie-Leblond I; Hammad H; Desurmont S; Pugin J; Wallaert B; Tonnel AB; Gosset P
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):586-92. PubMed ID: 10934091
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Analysis of the Th1/Th2 paradigm in transplantation: interferon-gamma deficiency converts Th1-type proislet allograft rejection to a Th2-type xenograft-like response.
    Simeonovic CJ; Townsend MJ; Karupiah G; Wilson JD; Zarb JC; Mann DA; Young IG
    Cell Transplant; 1999; 8(4):365-73. PubMed ID: 10478716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.